We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $832M
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
+26.8%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
–
AUM
$832M
AUM Growth
-$841M
Cap. Flow
-$871M
Cap. Flow %
-104.68%
Top 10 Hldgs %
85.7%
Holding
43
New
5
Increased
7
Reduced
7
Closed
8

Top Buys

Rank Stock Value
1
VIPS icon
Vipshop
VIPS
+$47.8M
2
FUTU icon
Futu Holdings
FUTU
+$44.7M
3
ALMR
Alamar Biosciences
ALMR
+$21.6M
4
ODTX
Odyssey Therapeutics
ODTX
+$14.6M
5
NTES icon
NetEase
NTES
+$4.13M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$339M
2
ONC
BeOne Medicines Ltd
ONC
+$307M
3
BABA icon
Alibaba
BABA
+$284M
4
BEKE icon
KE Holdings
BEKE
+$33.2M
5
CWAN
Clearwater Analytics
CWAN
+$32.3M

Sector Composition

Rank Sector Weight
1 Healthcare 50.75%
2 Financials 19.92%
3 Consumer Discretionary 12.41%
4 Technology 10.11%
5 Real Estate 3.87%

No holdings matched the selected filter criteria.

1 2

Similar funds

ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $832M AUM 5.47% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $832M AUM 49.88% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
AFA
AA Financial Advisors Columbus, Ohio $832M AUM 20.55% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $833M AUM 25.55% 1-Year Est. Return
AFA
American Financial Advisors Marietta, Georgia $831M AUM 21.38% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $833M AUM 22.71% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $835M AUM 73.7% 1-Year Est. Return

HHLR Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, HHLR Advisors held 43 positions worth $832M, down 50% from $1.67B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

HHLR Advisors withdrew a net $871M in Q2 2026, closing 8 positions and reducing 7 holdings. Its most notable exit was BeOne Medicines Ltd, an estimated $307M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 34% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, HHLR Advisors opened a new position in Alamar Biosciences worth $25.9M.

  • HHLR Advisors's largest Q2 2026 buy was Alamar Biosciences: 956,462 shares worth $25.9M.
  • HHLR Advisors added most to Vipshop in Q2 2026, an estimated $47.8M increase.
  • HHLR Advisors's biggest Q2 2026 reduction was Pinduoduo, cutting an estimated $339M.
  • HHLR Advisors fully exited BeOne Medicines Ltd in Q2 2026, selling an estimated $307M.
  • HHLR Advisors's ten largest holdings make up 86% of its $832M portfolio in Q2 2026.
  • HHLR Advisors opened 5 new positions and closed 8 in Q2 2026.
  • HHLR Advisors's portfolio value fell 50% quarter-over-quarter to $832M.

Based on HHLR Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.